This databook provides key data and information on the Analgesics Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
The analgesics category was valued at PKR6,718.2m ($95.4m) in 2009, representing a CAGR of 6.4% since 2004.
By the end of 2014, the analgesics category will be worth PKR8,539m ($121.3m), with an expected CAGR of 4.9% between 2009 and 2014.
The analgesics market was led by other analgesics (representing 75.2% of the total value) followed by ibuprofen and paracetamol, with an 11.7% and 8.4% market share, respectively. Aspirin accounts for the remaining 4.7% share.
Novartis AG is the market leader with a 24.7% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Analgesics Market in Pakistan (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements